Chronic-Dose Safety and Efficacy Study of Albuterol Inhaler in Pediatric Asthmatics
Study Title
- A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Teva Identifier
- ABS-AS-303
ClinicalTrials.gov Identifier
- NCT02126839
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Albuterol MDPI | Drug: Placebo | Drug: ProAir HFA inhaler
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 4 Years to 11 Years
Trial Duration
- 05/01/2014 - 02/01/2015
Phase
- Phase 3
Study Type
Interventional
